Xact Kapitalforvaltning’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Xact Kapitalforvaltning’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$128K	Hold	17,988	–	–	﹤0.01%	1264
2019 Q4	$430K	Buy	17,988 +7,200	+67%	+$199K	0.01%	1064
2019 Q3	$289K	Hold	10,788	–	–	0.01%	1219
2019 Q2	$293K	Hold	10,788	–	–	0.01%	1246
2019 Q1	$374K	Hold	10,788	–	–	0.01%	1094
2018 Q4	$211K	Buy	10,788 +1,200	+13%	+$24.7K	0.01%	1422
2018 Q3	$255K	Hold	9,588	–	–	0.01%	1453
2018 Q2	$362K	Sell	9,588 -200	-2%	-$7.65K	0.01%	1191
2018 Q1	$320K	Buy	9,788 +2,500	+34%	+$110K	0.01%	1200
2017 Q4	$355K	Buy	+7,288	New	+$369K	0.01%	826

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Xact Kapitalforvaltning's PTLA Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Portola Pharmaceuticals, Inc. (PTLA) position steady in Q1 2020 at 17,988 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Xact Kapitalforvaltning first reported a position in PTLA in Q4 2017 and has held it in 10 quarters since. The position peaked at $430K in Q4 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Xact Kapitalforvaltning held 17,988 shares of Portola Pharmaceuticals, Inc. worth $128K as of Q1 2020.
Xact Kapitalforvaltning left its Portola Pharmaceuticals, Inc. share count unchanged in Q1 2020.
Portola Pharmaceuticals, Inc. made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1264 holding.
Xact Kapitalforvaltning first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Portola Pharmaceuticals, Inc. position peaked at $430K in Q4 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.